Skip to main content

Table 2 Clinical characteristics and serum resistin levels of 124 hypertensive patients

From: High serum resistin levels are associated with peripheral artery disease in the hypertensive patients

Characteristic

Number (%)

Resistin (ng/mL)

p value

Sex

Male

82 (66.1)

7.26 (5.10–10.11)

0.631

Female

42 (33.9)

6.95 (5.60–11.98)

Diabetes

No

61 (49.2)

6.86 (5.12–10.01)

0.472

Yes

63 (50.8)

7.41 (5.24–10.89)

Dyslipidemia

No

25 (20.2)

7.23 (5.14–9.55)

0.818

Yes

99 (79.8)

7.18 (5.20–10.89)

ACE inhibitor

No

80 (64.5)

7.17 (5.14–10.81)

0.938

Yes

44 (35.5)

7.22 (5.26–10.16)

ARB

No

57 (46.0)

7.20 (4.91–10.44)

0.833

Yes

67 (54.0)

7.18 (5.24–10.19)

β-blocker

No

52 (41.9)

6.95 (5.34–9.22)

0.491

Yes

72 (58.1)

7.39 (4.94–11.74)

CCB

No

68 (54.8)

7.04 (4.67–10.16)

0.498

Yes

56 (45.2)

7.42 (5.40–10.79)

Statin

No

55 (44.6)

7.41 (5.68–10.55)

0.260

Yes

69 (55.4)

6.88 (4.77–10.02)

Fibrate

No

94 (75.8)

7.33 (5.36–10.51)

0.253

Yes

30 (24.2)

6.76 (4.56–8.56)

Aspirin

No

52 (41.9)

8.90 (5.78–10.24)

0.525

Yes

72 (58.1)

7.88 (4.92–10.16)

Clopidogrel

No

94 (75.8)

8.53 (5.36–10.17)

0.253

Yes

30 (24.2)

7.61 (4.56–8.56)

 
  1. Data are expressed as median and interquartile range after analysis by the Mann–Whitney U test
  2. ACE angiotensin-converting enzyme, ARB angiotensin-receptor blocker, CCB calcium-channel blocker
  3. *Values of p < 0.05 were considered statistically significant after analysis by the Mann–Whitney U test